Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature
American Journal of Case Reports · 23.04.2024 · 25
DOI: 10.12659/ajcr.944002 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, online erschienen am 23.04.2024. Verfasst von Jirapat Wonglhow und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Orbital Neoplasms, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Orbital metastasis originating from hepatocellular carcinoma (HCC), particularly as an initial manifestation in patients without a known history of HCC, is rare. Few reports exist on the treatment of patients having HCC with orbital metastasis using targeted therapy or immunotherapy. CASE REPORT We report a case of advanced-stage HCC in a 65-year-old man who first presented with progressive, painless blurred vision and proptosis of the right eye for 2 weeks. The patient had no history of chronic liver disease or cancer. Computed tomography revealed an enhancing hyperdense extraconal mass in the right orbit; a biopsy revealed metastatic HCC. Abdominal CT, which was performed to investigate the primary cancer, revealed a 1.2×1.6-cm arterial-enhancing nodule with venous washout in hepatic segment 5, associated with liver cirrhosis. The patient's serum alpha-fetoprotein level was 70.27 ng/dL. Chest computed tomography revealed lung metastasis. Thus, first-line systemic therapy combining durvalumab and tremelimumab was initiated alongside palliative radiotherapy targeting the right orbit, which began 1 week after the first dose of dual immunotherapy. The patient had significant clinical improvement, reduced proptosis, and serum alpha-fetoprotein levels. CONCLUSIONS Although orbital metastasis is a rare manifestation of HCC, physicians should recognize and consider aggressive investigations for early diagnosis, especially in patients with existing risk factors for HCC. Dual immunotherapy with durvalumab and tremelimumab in combination with radiotherapy can be considered a potential treatment option for managing advanced HCC with orbital metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
- Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
ORCID-Profile: Jirapat Wonglhow, Chirawadee Sathitruangsak, Panu Wetwittayakhlang
Zitieren
APA
Wonglhow, J., Dechaphunkul, A., Sunpaweravong, P., Sathitruangsak, C., Pajareeyaphan, S., & Wetwittayakhlang, P. (2024). Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature. American Journal of Case Reports, 25. https://doi.org/10.12659/ajcr.944002
Vancouver
Wonglhow J, Dechaphunkul A, Sunpaweravong P, Sathitruangsak C, Pajareeyaphan S, Wetwittayakhlang P. Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature. American Journal of Case Reports. 2024;25. doi:10.12659/ajcr.944002
BibTeX
@article{Wonglhow2024,
author = {Wonglhow, Jirapat and Dechaphunkul, Arunee and Sunpaweravong, Patrapim and Sathitruangsak, Chirawadee and Pajareeyaphan, Suchaya and Wetwittayakhlang, Panu},
title = {Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature},
journal = {American Journal of Case Reports},
year = {2024},
volume = {25},
doi = {10.12659/ajcr.944002}
}
EUVIMED